Healthcare value of implementing hepatitis C screening in the adult general population in Spain
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Healthcare value of implementing hepatitis C screening in the adult general population in Spain
Authors
Keywords
Hepatitis C virus, Chronic hepatitis, Hepatocellular carcinoma, Hepatitis C, Enzyme-linked immunoassays, Markov models, Fibrosis, Spain
Journal
PLoS One
Volume 13, Issue 11, Pages e0208036
Publisher
Public Library of Science (PLoS)
Online
2018-11-29
DOI
10.1371/journal.pone.0208036
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chronic hepatitis C and individuals with a history of injecting drugs in Spain
- (2017) Carlos Roncero et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Cost-Effectiveness of Access Expansion to Treatment of Hepatitis C Virus Infection Through Primary Care Providers
- (2017) Thilo Rattay et al. GASTROENTEROLOGY
- Cost-effectiveness analysis of ledipasvir/sofosbuvir in patients with chronic hepatitis C: Treatment of patients with absence or mild fibrosis compared to patients with advanced fibrosis
- (2017) M. Buti et al. JOURNAL OF VIRAL HEPATITIS
- In an era of highly effective treatment, hepatitis C screening of the United States general population should be considered
- (2017) Zobair Younossi et al. LIVER INTERNATIONAL
- Hepatitis C virus infection
- (2017) Michael P. Manns et al. Nature Reviews Disease Primers
- Estimating the Cost-Effectiveness of One-Time Screening and Treatment for Hepatitis C in Korea
- (2017) Do Young Kim et al. PLoS One
- Reversion of disease manifestations after HCV eradication
- (2016) Adriaan J. van der Meer et al. JOURNAL OF HEPATOLOGY
- The global burden of viral hepatitis from 1990 to 2013: findings from the Global Burden of Disease Study 2013
- (2016) Jeffrey D Stanaway et al. LANCET
- Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population
- (2016) Harinder S. Chahal et al. JAMA Internal Medicine
- Human Immunodeficiency Virus/Hepatitis C Virus Coinfection in Spain: Prevalence and Patient Characteristics
- (2016) Juan Berenguer et al. Open Forum Infectious Diseases
- Cost-effectiveness of all-oral ledipasvir/sofosbuvir regimens in patients with chronic hepatitis C virus genotype 1 infection
- (2015) Z. M. Younossi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Labour productivity losses caused by premature death associated with hepatitis C in Spain
- (2015) Juan Oliva-Moreno et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries
- (2015) Z. Younossi et al. JOURNAL OF VIRAL HEPATITIS
- Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
- (2015) Jordan J. Feld et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis C
- (2014) Ramón San Miguel et al. GUT
- Seroprevalence of HCV and HIV Infections by Year of Birth in Spain: Impact of US CDC and USPSTF Recommendations for HCV and HIV Testing
- (2014) Alvaro Mena et al. PLoS One
- Boceprevir for previously untreated patients with chronic hepatitis C Genotype 1 infection: a US-based cost-effectiveness modeling study
- (2013) Shannon Allen Ferrante et al. BMC INFECTIOUS DISEASES
- Eradication of Hepatitis C Virus in Patients Successfully Treated for Chronic Hepatitis C
- (2008) Sarah Maylin et al. GASTROENTEROLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More